Obesema 0.5 mg Injection
In stock
Description
Obesema Injection, manufactured by Alkem Laboratories Ltd, is a prescription, once-weekly subcutaneous injection containing Semaglutide, designed for long-term weight management, Type 2 diabetes control, and reducing cardiovascular risk in adults with obesity.
Specifications
| Active Ingredient | Semaglutide |
|---|---|
| Primary Application: | Chronic weight management and Type 2 Diabetes |
| Usage | Once-weekly, subcutaneous injection |
| Class | GLP-1 receptor agonist |
